Literature DB >> 31657556

Enhancing the Cell Permeability of Stapled Peptides with a Cyclic Cell-Penetrating Peptide.

Patrick G Dougherty1,2, Jin Wen1, Xiaoyan Pan1, Amritendu Koley1, Jian-Guo Ren2, Ashweta Sahni1, Ruchira Basu1, Heba Salim1, George Appiah Kubi1, Ziqing Qian1,2, Dehua Pei1.   

Abstract

Stapled peptides recapitulate the binding affinity and specificity of α-helices in proteins, resist proteolytic degradation, and may provide a novel modality against challenging drug targets such as protein-protein interactions. However, most of the stapled peptides have limited cell permeability or are impermeable to the cell membrane. We show herein that stapled peptides can be rendered highly cell-permeable by conjugating a cyclic cell-penetrating peptide to their N-terminus, C-terminus, or stapling unit. Application of this strategy to two previously reported membrane-impermeable peptidyl inhibitors against the MDM2/p53 and β-catenin/TCF interactions resulted in the generation of potent proof-of-concept antiproliferative agents against key therapeutic targets.

Entities:  

Year:  2019        PMID: 31657556      PMCID: PMC7291828          DOI: 10.1021/acs.jmedchem.9b00456

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  48 in total

Review 1.  Wnt/β-catenin signaling and disease.

Authors:  Hans Clevers; Roel Nusse
Journal:  Cell       Date:  2012-06-08       Impact factor: 41.582

2.  Structure-based design of high affinity peptides inhibiting the interaction of p53 with MDM2 and MDMX.

Authors:  Jason Phan; Zhenyu Li; Agnieszka Kasprzak; Baozong Li; Said Sebti; Wayne Guida; Ernst Schönbrunn; Jiandong Chen
Journal:  J Biol Chem       Date:  2009-11-12       Impact factor: 5.157

Review 3.  Peptide stapling techniques based on different macrocyclisation chemistries.

Authors:  Yu Heng Lau; Peterson de Andrade; Yuteng Wu; David R Spring
Journal:  Chem Soc Rev       Date:  2014-09-08       Impact factor: 54.564

4.  Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.

Authors:  P J Morin; A B Sparks; V Korinek; N Barker; H Clevers; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1997-03-21       Impact factor: 47.728

5.  Single turn peptide alpha helices with exceptional stability in water.

Authors:  Nicholas E Shepherd; Huy N Hoang; Giovanni Abbenante; David P Fairlie
Journal:  J Am Chem Soc       Date:  2005-03-09       Impact factor: 15.419

6.  Crystal structure of a beta-catenin/axin complex suggests a mechanism for the beta-catenin destruction complex.

Authors:  Yi Xing; Wilson K Clements; David Kimelman; Wenqing Xu
Journal:  Genes Dev       Date:  2003-11-04       Impact factor: 11.361

7.  Stapled α-helical peptide drug development: a potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy.

Authors:  Yong S Chang; Bradford Graves; Vincent Guerlavais; Christian Tovar; Kathryn Packman; Kwong-Him To; Karen A Olson; Kamala Kesavan; Pranoti Gangurde; Aditi Mukherjee; Theresa Baker; Krzysztof Darlak; Carl Elkin; Zoran Filipovic; Farooq Z Qureshi; Hongliang Cai; Pamela Berry; Eric Feyfant; Xiangguo E Shi; James Horstick; D Allen Annis; Anthony M Manning; Nader Fotouhi; Huw Nash; Lyubomir T Vassilev; Tomi K Sawyer
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-14       Impact factor: 11.205

8.  Toolbox of Diverse Linkers for Navigating the Cellular Efficacy Landscape of Stapled Peptides.

Authors:  Yuteng Wu; Amandeep Kaur; Elaine Fowler; Mareike M Wiedmann; Reginald Young; Warren R J D Galloway; Lasse Olsen; Hannah F Sore; Anasuya Chattopadhyay; Terence T-L Kwan; Wenshu Xu; Stephen J Walsh; Peterson de Andrade; Matej Janecek; Senthil Arumugam; Laura S Itzhaki; Yu Heng Lau; David R Spring
Journal:  ACS Chem Biol       Date:  2019-02-07       Impact factor: 4.634

Review 9.  Small-molecule inhibitors of the MDM2-p53 protein-protein interaction (MDM2 Inhibitors) in clinical trials for cancer treatment.

Authors:  Yujun Zhao; Angelo Aguilar; Denzil Bernard; Shaomeng Wang
Journal:  J Med Chem       Date:  2014-11-14       Impact factor: 7.446

10.  Design of Peptoid-peptide Macrocycles to Inhibit the β-catenin TCF Interaction in Prostate Cancer.

Authors:  Jeffrey A Schneider; Timothy W Craven; Amanda C Kasper; Chi Yun; Michael Haugbro; Erica M Briggs; Vladimir Svetlov; Evgeny Nudler; Holger Knaut; Richard Bonneau; Michael J Garabedian; Kent Kirshenbaum; Susan K Logan
Journal:  Nat Commun       Date:  2018-10-23       Impact factor: 14.919

View more
  13 in total

1.  Rational design of cell-permeable cyclic peptides containing a d-Pro-l-Pro motif.

Authors:  Jin Wen; Hui Liao; Kye Stachowski; Jordan P Hempfling; Ziqing Qian; Chunhua Yuan; Mark P Foster; Dehua Pei
Journal:  Bioorg Med Chem       Date:  2020-08-18       Impact factor: 3.641

2.  A Peptidyl Inhibitor that Blocks Calcineurin-NFAT Interaction and Prevents Acute Lung Injury.

Authors:  Patrick G Dougherty; Manjula Karpurapu; Amritendu Koley; Jessica K Lukowski; Ziqing Qian; Teja Srinivas Nirujogi; Luiza Rusu; Sangwoon Chung; Amanda B Hummon; Hao W Li; John W Christman; Dehua Pei
Journal:  J Med Chem       Date:  2020-10-19       Impact factor: 7.446

Review 3.  Targeting intracellular protein-protein interactions with macrocyclic peptides.

Authors:  Marina Buyanova; Dehua Pei
Journal:  Trends Pharmacol Sci       Date:  2021-12-13       Impact factor: 14.819

4.  Landscaping macrocyclic peptides: stapling hDM2-binding peptides for helicity, protein affinity, proteolytic stability and cell uptake.

Authors:  Aline D de Araujo; Junxian Lim; Kai-Chen Wu; Huy N Hoang; Huy T Nguyen; David P Fairlie
Journal:  RSC Chem Biol       Date:  2022-05-31

5.  Discovery of a Cyclic Cell-Penetrating Peptide with Improved Endosomal Escape and Cytosolic Delivery Efficiency.

Authors:  Marina Buyanova; Ashweta Sahni; Rui Yang; Amar Sarkar; Heba Salim; Dehua Pei
Journal:  Mol Pharm       Date:  2022-04-11       Impact factor: 5.364

6.  Development of Conformationally Constrained α-RgIA Analogues as Stable Peptide Antagonists of Human α9α10 Nicotinic Acetylcholine Receptors.

Authors:  Nan Zheng; Sean B Christensen; Alan Blakely; Cheryl Dowell; Landa Purushottam; J Michael McIntosh; Danny Hung-Chieh Chou
Journal:  J Med Chem       Date:  2020-07-16       Impact factor: 8.039

Review 7.  Modulating Protein-Protein Interactions by Cyclic and Macrocyclic Peptides. Prominent Strategies and Examples.

Authors:  Rosario González-Muñiz; María Ángeles Bonache; María Jesús Pérez de Vega
Journal:  Molecules       Date:  2021-01-16       Impact factor: 4.411

8.  Unprotected peptide macrocyclization and stapling via a fluorine-thiol displacement reaction.

Authors:  Md Shafiqul Islam; Samuel L Junod; Si Zhang; Zakey Yusuf Buuh; Yifu Guan; Mi Zhao; Kishan H Kaneria; Parmila Kafley; Carson Cohen; Robert Maloney; Zhigang Lyu; Vincent A Voelz; Weidong Yang; Rongsheng E Wang
Journal:  Nat Commun       Date:  2022-01-17       Impact factor: 14.919

9.  Discovery, X-ray structure and CPP-conjugation enabled uptake of p53/MDM2 macrocyclic peptide inhibitors.

Authors:  Anselm F L Schneider; Joerg Kallen; Johannes Ottl; Patrick C Reid; Sebastien Ripoche; Stephan Ruetz; Therese-Marie Stachyra; Samuel Hintermann; Christoph E Dumelin; Christian P R Hackenberger; Andreas L Marzinzik
Journal:  RSC Chem Biol       Date:  2021-08-26

Review 10.  Interfacial Peptides as Affinity Modulating Agents of Protein-Protein Interactions.

Authors:  Pavel V Ershov; Yuri V Mezentsev; Alexis S Ivanov
Journal:  Biomolecules       Date:  2022-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.